Additionally, decreased and subsequently unresponsive levels of c-peptide noted during the OGTT are reflective of decreased insulin secretion, also noted in humans with T2D, which is accompanied by reduced whole-body insulin sensitivity (Clark et al., 2001). The gene discussed is INS; the disease is type 2 diabetes mellitus.